Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000968440 | SCV001115892 | benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505468 | SCV002796467 | likely benign | Bartter disease type 5 | 2022-02-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000968440 | SCV005279320 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003928442 | SCV004740083 | benign | MAGED2-related disorder | 2019-09-30 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |